Company / Shareholders' Equity
cbdMD, Inc. Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$2.0M
FY2025
5-year range
$2.0M / $103.1M
FY2021-FY2025
Trend
-78.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has declined for 3 consecutive years, from $103M in FY2022 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -44.6%.
Declined from $31M to $2M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -73.3%
- 5-Year CAGR
- -44.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- cbdMD, Inc.'s shareholders' equity has declined for 3 consecutive years.
- 5-year CAGR of -44.6%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 78.3% year-over-year.
- Peak shareholders' equity was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0M | -78.3% |
| FY2024 | $9.0M | -71.3% |
| FY2023 | $31.4M | -69.5% |
| FY2022 | $103.1M | +30.3% |
| FY2021 | $79.2M | +110.6% |
| FY2020 | $37.6M | +198.3% |
| FY2019 | $12.6M | +0.0% |
| FY2018 | $12.6M | +199.3% |
| FY2017 | $4.2M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026